Industry: Chemical & Material
Published Date: 2024-01-17
Pages: 92 Pages
Report ld: 2296094
Request Sample
Customized Report
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
The global Lasmiditan Succinate market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Lasmiditan Succinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Lasmiditan Succinate is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Lasmiditan Succinate include Molnova, Excenen Pharmatech, Hubei Gedian Humanwell Pharma, Nantong HI-FUTURE Biology, ShiJiaZhuang Chirals Chemical and Shenzhen Shengda Pharma Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Lasmiditan Succinate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lasmiditan Succinate.
MARKET SEGMENTATION
REPORT SCOPE
The Lasmiditan Succinate market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Lasmiditan Succinate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lasmiditan Succinate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lasmiditan Succinate manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Lasmiditan Succinate by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Lasmiditan Succinate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Lasmiditan Succinate Market Overview
1.1 Product Definition
1.2 Lasmiditan Succinate Segment by Type
1.2.1 Global Lasmiditan Succinate Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥98%
1.2.3 Purity ≥99%
1.3 Lasmiditan Succinate Segment by Application
1.3.1 Global Lasmiditan Succinate Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Tablet
1.3.3 Oral Liquid
1.4 Global Market Growth Prospects
1.4.1 Global Lasmiditan Succinate Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Lasmiditan Succinate Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Lasmiditan Succinate Production Estimates and Forecasts (2019-2030)
1.4.4 Global Lasmiditan Succinate Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Lasmiditan Succinate Production Market Share by Manufacturers (2019-2024)
2.2 Global Lasmiditan Succinate Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Lasmiditan Succinate, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Lasmiditan Succinate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Lasmiditan Succinate Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Lasmiditan Succinate, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Lasmiditan Succinate, Product Offered and Application
2.8 Global Key Manufacturers of Lasmiditan Succinate, Date of Enter into This Industry
2.9 Lasmiditan Succinate Market Competitive Situation and Trends
2.9.1 Lasmiditan Succinate Market Concentration Rate
2.9.2 Global 5 and 10 Largest Lasmiditan Succinate Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Lasmiditan Succinate Production by Region
3.1 Global Lasmiditan Succinate Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Lasmiditan Succinate Production Value by Region (2019-2030)
3.2.1 Global Lasmiditan Succinate Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Lasmiditan Succinate by Region (2025-2030)
3.3 Global Lasmiditan Succinate Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Lasmiditan Succinate Production by Region (2019-2030)
3.4.1 Global Lasmiditan Succinate Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Lasmiditan Succinate by Region (2025-2030)
3.5 Global Lasmiditan Succinate Market Price Analysis by Region (2019-2024)
3.6 Global Lasmiditan Succinate Production and Value, Year-over-Year Growth
3.6.1 North America Lasmiditan Succinate Production Value Estimates and Forecasts (2019-2030)
3.6.2 China Lasmiditan Succinate Production Value Estimates and Forecasts (2019-2030)
3.6.3 Japan Lasmiditan Succinate Production Value Estimates and Forecasts (2019-2030)
4 Lasmiditan Succinate Consumption by Region
4.1 Global Lasmiditan Succinate Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Lasmiditan Succinate Consumption by Region (2019-2030)
4.2.1 Global Lasmiditan Succinate Consumption by Region (2019-2024)
4.2.2 Global Lasmiditan Succinate Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Lasmiditan Succinate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Lasmiditan Succinate Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Lasmiditan Succinate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Lasmiditan Succinate Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Lasmiditan Succinate Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Lasmiditan Succinate Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Lasmiditan Succinate Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Lasmiditan Succinate Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Lasmiditan Succinate Production by Type (2019-2030)
5.1.1 Global Lasmiditan Succinate Production by Type (2019-2024)
5.1.2 Global Lasmiditan Succinate Production by Type (2025-2030)
5.1.3 Global Lasmiditan Succinate Production Market Share by Type (2019-2030)
5.2 Global Lasmiditan Succinate Production Value by Type (2019-2030)
5.2.1 Global Lasmiditan Succinate Production Value by Type (2019-2024)
5.2.2 Global Lasmiditan Succinate Production Value by Type (2025-2030)
5.2.3 Global Lasmiditan Succinate Production Value Market Share by Type (2019-2030)
5.3 Global Lasmiditan Succinate Price by Type (2019-2030)
6 Segment by Application
6.1 Global Lasmiditan Succinate Production by Application (2019-2030)
6.1.1 Global Lasmiditan Succinate Production by Application (2019-2024)
6.1.2 Global Lasmiditan Succinate Production by Application (2025-2030)
6.1.3 Global Lasmiditan Succinate Production Market Share by Application (2019-2030)
6.2 Global Lasmiditan Succinate Production Value by Application (2019-2030)
6.2.1 Global Lasmiditan Succinate Production Value by Application (2019-2024)
6.2.2 Global Lasmiditan Succinate Production Value by Application (2025-2030)
6.2.3 Global Lasmiditan Succinate Production Value Market Share by Application (2019-2030)
6.3 Global Lasmiditan Succinate Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Molnova
7.1.1 Molnova Lasmiditan Succinate Corporation Information
7.1.2 Molnova Lasmiditan Succinate Product Portfolio
7.1.3 Molnova Lasmiditan Succinate Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Molnova Main Business and Markets Served
7.1.5 Molnova Recent Developments/Updates
7.2 Excenen Pharmatech
7.2.1 Excenen Pharmatech Lasmiditan Succinate Corporation Information
7.2.2 Excenen Pharmatech Lasmiditan Succinate Product Portfolio
7.2.3 Excenen Pharmatech Lasmiditan Succinate Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Excenen Pharmatech Main Business and Markets Served
7.2.5 Excenen Pharmatech Recent Developments/Updates
7.3 Hubei Gedian Humanwell Pharma
7.3.1 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Corporation Information
7.3.2 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Product Portfolio
7.3.3 Hubei Gedian Humanwell Pharma Lasmiditan Succinate Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Hubei Gedian Humanwell Pharma Main Business and Markets Served
7.3.5 Hubei Gedian Humanwell Pharma Recent Developments/Updates
7.4 Nantong HI-FUTURE Biology
7.4.1 Nantong HI-FUTURE Biology Lasmiditan Succinate Corporation Information
7.4.2 Nantong HI-FUTURE Biology Lasmiditan Succinate Product Portfolio
7.4.3 Nantong HI-FUTURE Biology Lasmiditan Succinate Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Nantong HI-FUTURE Biology Main Business and Markets Served
7.4.5 Nantong HI-FUTURE Biology Recent Developments/Updates
7.5 ShiJiaZhuang Chirals Chemical
7.5.1 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Corporation Information
7.5.2 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Product Portfolio
7.5.3 ShiJiaZhuang Chirals Chemical Lasmiditan Succinate Production, Value, Price and Gross Margin (2019-2024)
7.5.4 ShiJiaZhuang Chirals Chemical Main Business and Markets Served
7.5.5 ShiJiaZhuang Chirals Chemical Recent Developments/Updates
7.6 Shenzhen Shengda Pharma Limited
7.6.1 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Corporation Information
7.6.2 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Product Portfolio
7.6.3 Shenzhen Shengda Pharma Limited Lasmiditan Succinate Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Shenzhen Shengda Pharma Limited Main Business and Markets Served
7.6.5 Shenzhen Shengda Pharma Limited Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Lasmiditan Succinate Industry Chain Analysis
8.2 Lasmiditan Succinate Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lasmiditan Succinate Production Mode & Process
8.4 Lasmiditan Succinate Sales and Marketing
8.4.1 Lasmiditan Succinate Sales Channels
8.4.2 Lasmiditan Succinate Distributors
8.5 Lasmiditan Succinate Customers
9 Lasmiditan Succinate Market Dynamics
9.1 Lasmiditan Succinate Industry Trends
9.2 Lasmiditan Succinate Market Drivers
9.3 Lasmiditan Succinate Market Challenges
9.4 Lasmiditan Succinate Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 126
USD 3950.00
(Single User License)
The global Lasmiditan Succinate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-18
Pages: 127
USD 2900.00
(Single User License)
The global Lasmiditan Succinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-10
Pages: 80
USD 4250.00
(Single User License)
The global Lasmiditan Succinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-08
Pages: 137
USD 4900.00
(Single User License)
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 93
USD 3950.00
(Single User License)
The global market for Lasmiditan Succinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 93
USD 2900.00
(Single User License)
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published Date: 2024-04-15
Pages: 90
USD 4900.00
(Single User License)
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 126
The global Lasmiditan Succinate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-18
Pages: 127
The global Lasmiditan Succinate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-10
Pages: 80
The global Lasmiditan Succinate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-08
Pages: 137
The global market for Lasmiditan Succinate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 93
The global market for Lasmiditan Succinate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 93
Lamiditan succinate, also known as lamitetan perate, is an oral prescription drug for the acute treatment of migraine in adults with or without aura.
Published: 2024-04-15
Pages: 90
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now